41
Participants
Start Date
July 5, 2014
Primary Completion Date
June 18, 2015
Study Completion Date
June 18, 2015
S-1+leucovorin
"Eligible patients will receive TS-1 orally 40-60 mg (depending on patient's body surface area (BSA)) in combination with calcium folinate 30 mg twice a day for 7 days in a 2-week cycle.~The treatment will be administered until disease progression, intolerable toxicity, or consent withdrawal during any time of the study."
Chang-Gung Memorial Hospital, Linkou, Linkou District
Chang Gung Memorial Hospital
OTHER
TTY Biopharm
INDUSTRY